183 related articles for article (PubMed ID: 25854398)
1. Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun S; Jin GJ; Zhao Y; Kang H
Asian Pac J Cancer Prev; 2015; 16(7):3009-14. PubMed ID: 25854398
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.
Zhong JH; You XM; Gong WF; Ma L; Zhang Y; Mo QG; Wu LC; Xiao J; Li LQ
PLoS One; 2012; 7(3):e32159. PubMed ID: 22403631
[TBL] [Abstract][Full Text] [Related]
3. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.
Yang Z; Wu Q; Shi Y; Nie Y; Wu K; Fan D
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1086-91. PubMed ID: 22852842
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
Chen K; Wei Y; Yang H; Li B
Genet Test Mol Biomarkers; 2011 Apr; 15(4):251-5. PubMed ID: 21186997
[TBL] [Abstract][Full Text] [Related]
6. CCND1 rs9344 polymorphism is associated with the risk of hepatocellular carcinoma in Caucasian population.
Wang DD; Duan WD; Zhu ZM; Tu YL; Dou CQ; Han MM; Zhang B; Zhao W; Jiang K
J Cancer Res Ther; 2018 Jun; 14(Supplement):S516-S518. PubMed ID: 29970717
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the relationship between microRNA-499 rs3746444 polymorphism and hepatocellular carcinoma risk in Asians.
Wang W; Qin H; Zhou L; Ma J
J Cancer Res Ther; 2016; 12(2):676-80. PubMed ID: 27461631
[TBL] [Abstract][Full Text] [Related]
8. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis.
Wei YG; Liu F; Li B; Chen X; Ma Y; Yan LN; Wen TF; Xu MQ; Wang WT; Yang JY
World J Gastroenterol; 2011 Sep; 17(34):3941-7. PubMed ID: 22025883
[TBL] [Abstract][Full Text] [Related]
10. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
Li YL; Tian Z; Zhao L; Zhang CL
Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191
[TBL] [Abstract][Full Text] [Related]
11. Association between the HSPA1B ±1267A/G polymorphism and cancer risk: a meta-analysis of 14 case-control studies.
Kuang D; Chen W; Song YZ; Yu YY; Zhang DY; Wu L; Tang J
Asian Pac J Cancer Prev; 2014; 15(16):6855-61. PubMed ID: 25169537
[TBL] [Abstract][Full Text] [Related]
12. Study of the association between five polymorphisms and risk of hepatocellular carcinoma: A meta-analysis.
Yu JY; Hu F; Du W; Ma XL; Yuan K
J Chin Med Assoc; 2017 Apr; 80(4):191-203. PubMed ID: 28188097
[TBL] [Abstract][Full Text] [Related]
13. Association between +61G polymorphism of the EGF gene and glioma risk in different ethnicities: a meta-analysis.
Tan D; Xu J; Li Y; Lai R
Tohoku J Exp Med; 2010 Dec; 222(4):229-35. PubMed ID: 21123997
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of ALDH2 and ADH2 are not associated with risk of hepatocellular carcinoma among East Asians.
Zhou D; Xiao L; Zhang Y; Xian J; Jiang J; Zong W; Huang Z; Yang Y
Tumour Biol; 2012 Jun; 33(3):841-6. PubMed ID: 22231434
[TBL] [Abstract][Full Text] [Related]
15. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
16. Association between epidermal growth factor gene rs4444903 polymorphism and risk of glioma.
Hu M; Shi H; Xu Z; Liu W
Tumour Biol; 2013 Jun; 34(3):1879-85. PubMed ID: 23645212
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies.
Yuan JM; Fan Y; Ognjanovic S; Wang R; Van Den Berg D; Govindarajan S; Yu MC
BMC Gastroenterol; 2013 Feb; 13():32. PubMed ID: 23419149
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
[TBL] [Abstract][Full Text] [Related]
19. TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls.
Fang F; Yao L; Yu XJ; Yu L; Wu Q; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(1):267-71. PubMed ID: 20035378
[TBL] [Abstract][Full Text] [Related]
20. Association between the NQO1 C609T polymorphism with hepatocellular carcinoma risk in the Chinese population.
Zhao H; Zou LW; Zheng SS; Geng XP
Asian Pac J Cancer Prev; 2015; 16(5):1821-5. PubMed ID: 25773831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
